Bell's Palsy Steroid Tapering Guidelines
For adults with Bell's palsy, prescribe prednisolone 50-60 mg daily (or prednisone 60 mg daily) for 5 days, followed by a 5-day taper, initiated within 72 hours of symptom onset. 1, 2
Standard Dosing Regimen
The evidence-based approach from the AAO-HNS clinical practice guideline establishes:
- Initial dose: Prednisolone 50 mg twice daily (total 100 mg/day) OR prednisone 60 mg once daily
- Duration at full dose: 5 days
- Taper period: 5 days (gradual reduction)
- Total treatment duration: 10 days
- Critical timing window: Must begin within 72 hours of symptom onset 1, 2
The landmark Sullivan trial used prednisolone 25 mg twice daily for 10 days, while the Engström trial used 60 mg daily for 5 days with a 5-day taper—both demonstrated significant benefit with 83-94% recovery rates versus 63-82% in placebo groups 1, 3.
Specific Taper Schedule
Days 1-5: Full dose (prednisone 60 mg daily or prednisolone 50 mg daily)
Days 6-10: Gradual taper over 5 days. While the guidelines don't specify exact daily reductions, a practical approach would be:
- Day 6: 50 mg
- Day 7: 40 mg
- Day 8: 30 mg
- Day 9: 20 mg
- Day 10: 10 mg
No extended tapering beyond 10 days is recommended or necessary for Bell's palsy treatment 1.
Patients with Diabetes Mellitus
Diabetes is NOT a contraindication to steroid therapy for Bell's palsy. The evidence demonstrates:
- High-dose steroid therapy achieves 97.4% cure rates in diabetic patients with complete facial palsy 4
- Recovery times do not differ between diabetic and non-diabetic patients 5
- Steroid-treated diabetic patients show only modest acute glucose elevation (162.4 vs 152.4 mg/dL) with no significant difference in HbA1c at 1-6 months 6
- Risk of hyperosmolar hyperglycemic state increases slightly (1.82% vs 0.57%, NNH=80), but DKA rates are not significantly different 6
Management approach for diabetic patients:
- Use the same steroid dosing regimen (do not reduce dose)
- Monitor glucose closely during treatment period
- Adjust diabetes medications temporarily as needed
- Counsel patients about transient hyperglycemia risk
- The functional benefit of steroid therapy outweighs the modest, temporary glycemic impact 5, 4, 6
Active Infection Considerations
The guidelines do not specifically address active infection as a contraindication. However, applying general steroid principles:
- Localized infections (e.g., skin, urinary): Treat infection concurrently; steroids can still be given
- Systemic infections requiring antibiotics: Consider delaying steroids 24-48 hours until antibiotics initiated, though this may compromise the 72-hour treatment window
- Severe sepsis/septic shock: Contraindicated—do not give steroids for Bell's palsy in this setting
The 72-hour window is critical for efficacy, so minor infections should not delay treatment 1, 2.
Pediatric Considerations
For children under 16 years: The evidence for steroid benefit is less clear, with spontaneous recovery rates up to 90% 7. The AAO-HNS guideline states there is "no firm evidence for routine use of steroids in children" but suggests they "may be considered" given the similar disease process and favorable benefit-harm ratio 1. If treating pediatric patients, use the same dosing regimen adjusted for weight, with significant caregiver involvement in decision-making.
Critical Practice Points
- Do NOT use antiviral monotherapy—it is ineffective 1, 2, 8
- Do NOT perform routine laboratory testing (including Lyme serology unless endemic area with specific risk factors) 1, 2
- Do NOT obtain routine imaging (CT/MRI) for typical Bell's palsy presentation 1, 2
- Do NOT extend treatment beyond 10 days—no additional benefit and increases adverse effects
- Treatment benefit after 72 hours is unclear; spontaneous recovery becomes more likely 1
Combination Therapy Option
Antivirals (valacyclovir 1g TID for 7 days or acyclovir 400mg 5x daily for 10 days) may be added to steroids, though benefit is uncertain and likely modest at best (Level C recommendation) 1, 2, 8. If used, always combine with steroids—never give antivirals alone.